1.18
price down icon1.60%   -0.0192
after-market Dopo l'orario di chiusura: 2.59 1.41 +119.49%
loading

Dyadic International Inc De Borsa (DYAI) Ultime notizie

pulisher
May 01, 2025

Dyadic International, Inc. to Announce First Quarter 2025 Financial Results and Host Conference Call on May 14, 2025 - Nasdaq

May 01, 2025
pulisher
May 01, 2025

Dyadic to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025 - Eagle-Tribune

May 01, 2025
pulisher
May 01, 2025

Biotech Pioneer Dyadic Schedules Q1 2025 Earnings Call to Discuss Protein Manufacturing Progress - Stock Titan

May 01, 2025
pulisher
Apr 29, 2025

Dyadic International director to retire in June - Investing.com Australia

Apr 29, 2025
pulisher
Apr 29, 2025

Dyadic International director to retire in June By Investing.com - Investing.com India

Apr 29, 2025
pulisher
Apr 29, 2025

Dyadic International Director Arindam Bose Announces Retirement - TipRanks

Apr 29, 2025
pulisher
Apr 17, 2025

Dyadic International, Inc. (NASDAQ:DYAI) Sees Large Increase in Short Interest - Defense World

Apr 17, 2025
pulisher
Apr 17, 2025

Captivision Inc. (NASDAQ:CAPTW) Short Interest Down 42.5% in March - Defense World

Apr 17, 2025
pulisher
Apr 17, 2025

Short Interest in Capcom Co., Ltd. (OTCMKTS:CCOEF) Rises By 74.5% - Defense World

Apr 17, 2025
pulisher
Apr 16, 2025

Dyadic International, Inc. CEO to Present at 2025 World Vaccine Congress on Advancements in Biomanufacturing for Vaccines - Nasdaq

Apr 16, 2025
pulisher
Apr 16, 2025

Dyadic to Present at World Vaccine Congress | Washington - GlobeNewswire

Apr 16, 2025
pulisher
Mar 27, 2025

Dyadic’s Earnings Call: Growth Amid Challenges - TipRanks

Mar 27, 2025
pulisher
Mar 27, 2025

Dyadic Reports 2024 Year-End Financial Results and Business Updates - GlobeNewswire

Mar 27, 2025
pulisher
Mar 27, 2025

Dyadic International Reports Strong 2024 Revenue Growth - TipRanks

Mar 27, 2025
pulisher
Mar 26, 2025

Earnings call transcript: Dyadic Q4 2024 shows revenue beat, EPS miss - Investing.com Australia

Mar 26, 2025
pulisher
Mar 26, 2025

Earnings call transcript: Dyadic Q4 2024 shows revenue beat, EPS miss By Investing.com - Investing.com South Africa

Mar 26, 2025
pulisher
Mar 26, 2025

Dyadic International Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 26, 2025
pulisher
Mar 26, 2025

DYADIC INTERNATIONAL Earnings Results: $DYAI Reports Quarterly Earnings - Nasdaq

Mar 26, 2025
pulisher
Mar 26, 2025

Dyadic Boosts Revenue 20%, Lands Major Gates Foundation and CEPI Backing - Stock Titan

Mar 26, 2025
pulisher
Mar 25, 2025

Specialty Enzymes Market Competitive Analysis and Growth Opportunities 2025-2032 - Newstrail

Mar 25, 2025
pulisher
Mar 24, 2025

Dyadic International Inc expected to post a loss of 4 cents a shareEarnings Preview - TradingView

Mar 24, 2025
pulisher
Mar 24, 2025

Dyadic (NASDAQ: DYAI) Secures $3M Gates Foundation Grant - openPR.com

Mar 24, 2025
pulisher
Mar 20, 2025

Dyadic International Secures $4.5M for Vaccine Development - TipRanks

Mar 20, 2025
pulisher
Mar 20, 2025

Breakthrough: New Dyadic Technology Slashes Vaccine Production Time from 6 Months to 35 Days - StockTitan

Mar 20, 2025
pulisher
Mar 19, 2025

Dyadic International (DYAI) to Release Earnings on Wednesday - Defense World

Mar 19, 2025
pulisher
Mar 18, 2025

Key Trend Shaping the Enzyme Stabilizer Market in 2025: Innovative Oral Enzyme Stabilizers Enhance Efficacy... - WhaTech

Mar 18, 2025
pulisher
Mar 17, 2025

Short Interest in Dyadic International, Inc. (NASDAQ:DYAI) Declines By 19.9% - The AM Reporter

Mar 17, 2025
pulisher
Mar 12, 2025

Dyadic to Report 2024 Full Year Financial Results and Host Conference call on Wednesday, March ... - Bluefield Daily Telegraph

Mar 12, 2025
pulisher
Mar 12, 2025

Biotech Leader Dyadic Sets Date for 2024 Financial Results: Key Details for Investors - StockTitan

Mar 12, 2025
pulisher
Mar 12, 2025

Industrial Enzymes Market Set For 7.1% Growth, Reaching $10.14 Billion By 2029 - WhaTech

Mar 12, 2025
pulisher
Mar 11, 2025

Industrial Enzymes Global Industry Forecast Report and Company Analysis 2024-2030 Featuring BASF, Advanced Enzyme Technologies, Novozymes, DuPont Danisco, DSM, Kerry, Dyadic, Associated British Foods - GlobeNewswire Inc.

Mar 11, 2025
pulisher
Mar 11, 2025

Industrial Enzymes Global Industry Forecast Report and - GlobeNewswire

Mar 11, 2025
pulisher
Mar 11, 2025

Key Cellulase Market Trend 2025-2034: Product Innovation In The Cellulase Market In New Report - WhaTech

Mar 11, 2025
pulisher
Mar 06, 2025

Dyadic to Attend Multiple Industry Events in March - Bluefield Daily Telegraph

Mar 06, 2025
pulisher
Mar 06, 2025

Can These 3 Major Biotech Events Accelerate Dyadic's Market Position? - StockTitan

Mar 06, 2025
pulisher
Mar 05, 2025

Jeans to Genes - Florida Trend

Mar 05, 2025
pulisher
Feb 10, 2025

3 US Penny Stocks With Market Caps Over $40M To Consider - Simply Wall St

Feb 10, 2025
pulisher
Feb 07, 2025

DYAI: Looking Toward Product Revenues - Zacks Small Cap Research

Feb 07, 2025
pulisher
Feb 04, 2025

Global Enzymes Market Set for Robust Growth: Projected to Reach USD 20.4 Billion by 2029 As Discussed In Ne... - WhaTech

Feb 04, 2025
pulisher
Jan 30, 2025

Food Enzymes Market to grow by USD 1.04 Billion from 2025-2029, driven by rising demand from beverage industry, Report on AI's role in market transformationTechnavio - The Malaysian Reserve

Jan 30, 2025
pulisher
Jan 27, 2025

Food Enzymes Market Research Report 2025-2033, Featuring - GlobeNewswire

Jan 27, 2025
pulisher
Jan 24, 2025

Enzymes Market Size, Top Companies, Sales Volume and Global Share Forecast Report - WICZ

Jan 24, 2025
pulisher
Jan 23, 2025

Robust Growth in Protein Hydrolysis Enzymes Market: Insights on Market Dynamics, Key Players, and Emerging Trends - openPR

Jan 23, 2025
pulisher
Jan 21, 2025

Proteases Global Market Report 2025: Robust Growth, Key Players, and Emerging Trends - openPR

Jan 21, 2025
pulisher
Jan 06, 2025

Dyadic Advances Protein Platform with Key Launches, Gates Foundation Backs Vaccine Research - StockTitan

Jan 06, 2025
pulisher
Dec 18, 2024

Dyadic International And 2 Other US Penny Stocks To Watch - Yahoo Finance

Dec 18, 2024
pulisher
Dec 06, 2024

Alcohol and Starch Enzyme Market (2024-2032): Industry - openPR

Dec 06, 2024
pulisher
Dec 03, 2024

Biocatalysts Market Competition & Segment Analysis - openPR

Dec 03, 2024
pulisher
Nov 28, 2024

Hyperscale Data, Inc. (NYSEAMERICAN: GPUS) Announces Distribution of Series F Exchangeable Preferred Stock - Defense World

Nov 28, 2024
pulisher
Nov 25, 2024

Specialty Enzymes Industry Research Report 2024: Global - GlobeNewswire

Nov 25, 2024
pulisher
Nov 25, 2024

Cellulase Market 2024 Global Trends & 2033 Forecast: Growth Insights & Analysis In The Latest Report - WhaTech

Nov 25, 2024
pulisher
Nov 25, 2024

Specialty Enzymes Industry Research Report 2024: Global Market to Reach $9 Billion by 2030 with Personalized Medicine and Eco-Friendly Solutions Driving Developments - GlobeNewswire

Nov 25, 2024
pulisher
Nov 21, 2024

Dyadic Secures $3M Gates Foundation Grant for RSV, Malaria Antibody Development | DYAI Stock News - StockTitan

Nov 21, 2024
pulisher
Nov 19, 2024

In-Depth Analysis Of The Global Erythropoietin (EPO) Market: Key Drivers, Trends, And Forecast 2024-2033 - EIN News

Nov 19, 2024
pulisher
Nov 18, 2024

Earnings call: Dyadic International reports robust Q3 growth - Investing.com

Nov 18, 2024
pulisher
Nov 18, 2024

Top US Penny Stocks To Watch In November 2024 - Yahoo Finance

Nov 18, 2024
pulisher
Nov 15, 2024

Dyadic International Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Nov 15, 2024
pulisher
Nov 13, 2024

Bakery Enzymes Market Future Growth Analysis, 2032 - WICZ

Nov 13, 2024
pulisher
Nov 12, 2024

Dyadic Announces Third Quarter 2024 Financial Results and Strategic Progress Across Key Markets - StockTitan

Nov 12, 2024
pulisher
Nov 04, 2024

Dyadic to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024 - GlobeNewswire

Nov 04, 2024
$72.58
price up icon 0.39%
$21.55
price up icon 0.33%
$33.00
price up icon 0.33%
$28.02
price up icon 0.43%
$101.10
price down icon 3.66%
biotechnology ONC
$254.16
price down icon 0.63%
Capitalizzazione:     |  Volume (24 ore):